Determining the capability of a test compound to affect solid tumor stem cells

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8044259
APP PUB NO 20080178305A1
SERIAL NO

11776935

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A small percentage of cells within an established solid tumor have the properties of stem cells. These solid tumor stem cells give rise both to more tumor stem cells and to the majority of cells in the tumor that have lost the capacity for extensive proliferation and the ability to give rise to new tumors. Thus, solid tumor heterogeneity reflects the presence of tumor cell progeny arising from a solid tumor stem cell. We have developed a xenograft model in which we have been able to establish tumors from primary tumors via injection of tumor cells in the mammary gland of severely immunodeficient mice. These xenograft assay have allowed us to do biological and molecular assays to characterize clonogenic solid tumor stem cells. We have also developed evidence that strongly implicates the Notch pathway, especially Notch 4, as playing a central pathway in carcinogenesis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ONCOMED PHARMACEUTICALS INC800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063-4748

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Clarke, Michael F Menlo Park, US 65 2950
Dylla, Scott J Mountain View, US 66 551
Satyal, Sanjeev San Carlos, US 30 448

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation